STMN1, SMARCC1, ALDOA, CLTC, PSMG1, SUZ12, DAG1, PGRMC1, and HMGCR, and MYO10 were upregulated following compound treatment Additionally, the compounds against Alzheimer’s disease were identified and their BBB permeability levels were predicted. This evidence concerns the gene SUZ12 and Alzheimer disease.